Get started
Author

Sidi Yang

Salmonella Effector SpvB Disrupts Intestinal Epithelial Barrier Integrity for Bacterial Translocation
2020 · Lanqing Sun, Sidi Yang, et al. · Frontiers in Cellular and Infection Microbiology · 62
PDF
Stromal-epithelial metabolic coupling in gastric cancer: Stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors
2014 · Z. Zhao, F. Han, et al. · European Journal of Surgical Oncology · 61
SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis
2023 · Lihong Liu, Jie Du, et al. · Redox Biology · 55
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19
2024 · Yongzhi Lu, Qi Yang, et al. · Nature Communications · 48
PDF
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
2022 · Liu Cao, Yingjun Li, et al. · Science Translational Medicine · 47
Salmonella effector SpvB interferes with intracellular iron homeostasis via regulation of transcription factor NRF2
2019 · Sidi Yang, Qifeng Deng, et al. · The FASEB Journal · 41
Salmonella pSLT-encoded effector SpvB promotes RIPK3-dependent necroptosis in intestinal epithelial cells
2022 · Kedi Dong, Yuan Zhu, et al. · Cell Death Discovery · 28
PDF
Salmonella Effector SpvB Inhibits NF-κB Activity via KEAP1-Mediated Downregulation of IKKβ
2021 · Sidi Yang, Qifeng Deng, et al. · Frontiers in Cellular and Infection Microbiology · 25
PDF
Salmonella effector SpvB aggravates dysregulation of systemic iron metabolism via modulating the hepcidin−ferroportin axis
2021 · Qifeng Deng, Sidi Yang, et al. · Gut Microbes · 24
Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2
2023 · Yujian Yang, Liu Cao, et al. · Antiviral Research · 22
PDF
A detrimental role of NLRP6 in host iron metabolism during Salmonella infection
2021 · Qifeng Deng, Sidi Yang, et al. · Redox Biology · 17
spv locus aggravates Salmonella infection of zebrafish adult by inducing Th1/Th2 shift to Th2 polarization
2017 · Shu-yan Wu, Li-dan Wang, et al. · Fish & Shellfish Immunology · 15
Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside
2023 · Qifan Zhou, Sidi Yang, et al. · Signal Transduction and Targeted Therapy · 14
PDF
Comparison of model‐specific histopathology in mouse models of COVID‐19
2022 · Sidi Yang, Liu Cao, et al. · Journal of Medical Virology · 11
Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses
2025 · Tiefeng Xu, Kun Li, et al. · Acta Pharmaceutica Sinica B · 9
A soluble DR5‐Fc chimeric protein attenuates inflammatory responses induced by coronavirus MHV‐A59 and SARS‐CoV‐2
2022 · Hong Peng, Birong Zheng, et al. · Journal of Medical Virology · 6
Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High‐Throughput Antiviral Screening Using Gibson DNA Assembly
2025 · Xinrong Zhou, Hongchao Liu, et al. · Journal of Medical Virology · 5
Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities
2024 · Fan Pan, Qifan Zhou, et al. · Bioorganic Chemistry · 5
Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection
2024 · Qishu Chen, Qifan Zhou, et al. · Bioorganic Chemistry · 5
REV-ERBα negatively regulates NLRP6 transcription and reduces the severity of Salmonella infection in mice
2024 · Lanqing Sun, Kai Huang, et al. · Heliyon · 5
NLRP6 induces RIP1 kinase-dependent necroptosis via TAK1-mediated p38MAPK/MK2 phosphorylation in S. typhimurium infection
2024 · Qifeng Deng, Sidi Yang, et al. · iScience · 5
Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2
2022 · Weijie Zeng, Fan Xing, et al. · Frontiers in Cellular and Infection Microbiology · 5
Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity
2025 · Yuanmei Wen, Jun Zhou, et al. · ACS Infectious Diseases · 4
Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment
2025 · Peisen Zheng, Guanguan Li, et al. · Bioorganic & Medicinal Chemistry Letters · 3
Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release
2026 · Liwei Zheng, Minghui Li, et al. · Cell Reports · 2
Works count: 37
Citation count: 531
H-index: 13
I10-index: 14
Year
Topic
Type